Akari Therapeutics PLC (AKTX) — Strategic Asset Allocation Index
Akari Therapeutics PLC (AKTX) has a Strategic Asset Allocation Index of 0.1% as of March 2020. Strategic assets (PP&E of $2.10K plus long-term investments of $-) total $2.10K, measured against net assets of $1.82 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Akari Therapeutics PLC Strategic Asset Allocation Index (2014–2019)
This chart shows how Akari Therapeutics PLC's Strategic Asset Allocation Index has evolved across 6 annual periods from 2014 to 2019. As of March 2020, the index stands at 0.1%, representing strategic assets of $2.10K against net assets of $1.82 Million USD. Explore Akari Therapeutics PLC (AKTX) cash conversion ratio to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Akari Therapeutics PLC (2014–2019)
The table below presents the year-by-year Strategic Asset Allocation Index for Akari Therapeutics PLC from 2014 to 2019, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see how much is Akari Therapeutics PLC worth.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2019 | 0.1% | $5.01K | $5.01K | $- | $3.84 Million | ▼ 0.0 pp |
| 2018 | 0.2% | $20.43K | $20.43K | $- | $13.38 Million | ▼ -0.1 pp |
| 2017 | 0.3% | $55.90K | $55.90K | $- | $19.98 Million | ▲ +0.1 pp |
| 2016 | 0.2% | $58.36K | $58.36K | $- | $34.10 Million | ▲ +0.1 pp |
| 2015 | 0.1% | $40.51K | $40.51K | $- | $48.72 Million | ▲ +0.1 pp |
| 2014 | 0.0% | $0.00 | $0.00 | $- | $4.85 Million | — |